PGN-202

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug NamePGN-202
Drug Alias NameNTDDS expressing enkephalinNP-2 (Periphagen)PGN-202NET-ENK
ClassificationBiologics
Mechanisms of ActionNeprilysin inhibitorsGene transference
TargetsNeprilysin
Therapy Area/IndicationsPain, IntractableNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPeriphagen Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiamyd, Inc
Active IndicationsN/A
Inactive IndicationsPain, IntractableNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A